Literature DB >> 24737105

[Update: standardized CT/HRCT classification of occupational and environmental thoracic diseases in Germany].

K G Hering1, K Hofmann-Preiß, T Kraus.   

Abstract

The high-resolution computed tomography (HRCT) coding scheme of the international classification of occupational and environmental respiratory diseases (ICOERD) presented here is an instrument for a standardized semiquantitative description of occupation and environment-linked as well as other pulmonary and pleural diseases. Analogous to the International Labour Organization (ILO) classification, the ICOERD coding scheme should always be used when the CT/HRCT examination is employed for occupational medical investigations or expert opinions. After publication of the guidelines and recommendations on diagnostics and expert assessment of asbestos-linked diseases and silicosis, the application of a standardized investigation program and assessment with the ICOERD classification form are obligatory, at least for the initial assessment. Furthermore, its use in the field of follow-up assessments of occupational diseases should be encouraged in order to guarantee comparability between individual reports (interreader variability) and at least a semiquantitative assessment of disease progression in isolated cases. Because the anatomical structures in projection radiography and CT are not presented identically, a 1:1 transfer of the results of the ILO classification to the CT/HRCT coding scheme is not possible. An overview image of the thorax does not allow overlap-free reproduction of structures, in contrast to CT. These methodological differences can in cases of isolated assessment result in different opinions of projection and CT images mostly by different investigators. In cases of discrepant opinions an integrated report of findings by combination of all information from both procedures is necessary.

Entities:  

Mesh:

Year:  2014        PMID: 24737105     DOI: 10.1007/s00117-014-2674-y

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  16 in total

1.  [Evaluation and classification of CT findings in work-related lung and pleural changes in accordance with the ILO pneumoconiosis classification].

Authors:  K G Hering
Journal:  Rontgenpraxis       Date:  1992-09

Review 2.  [Asbestos-related diseases of the thorax].

Authors:  H-G Hieckel; K G Hering
Journal:  Radiologe       Date:  2010-07       Impact factor: 0.635

3.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

Review 4.  Pneumoconiosis: comparison of imaging and pathologic findings.

Authors:  Semin Chong; Kyung Soo Lee; Myung Jin Chung; Joungho Han; O Jung Kwon; Tae Sung Kim
Journal:  Radiographics       Date:  2006 Jan-Feb       Impact factor: 5.333

Review 5.  [Examples for asbestos-related findings in HRCT - criteria for the assessment of causal relationships in surveillance programmes and medical expert opinion].

Authors:  T Kraus; E Borsch-Galetke; H J Elliehausen; K Frank; K G Hering; H G Hieckel; K Hofmann-Preiss; W Jacques; U Jeremie; N Kotschy-Lang; E Mannes; H Otten; W Raab; H J Raithel; W D Schneider; S Tuengerthal
Journal:  Pneumologie       Date:  2009-12-11

6.  Early asbestosis: evaluation with high-resolution CT.

Authors:  M Akira; K Yokoyama; S Yamamoto; T Higashihara; K Morinaga; N Kita; S Morimoto; J Ikezoe; T Kozuka
Journal:  Radiology       Date:  1991-02       Impact factor: 11.105

7.  [Diagnostics and expert opinion of asbestos-induced occupational diseases].

Authors:  X Baur; M Clasen; A Fisseler-Eckhoff; M Heger; K G Hering; K Hofmann-Preiss; D Köhler; A Kranig; T Kraus; S Letzel; V Neumann; A Tannapfel; J Schneider; H Sitter; H Teschler; T Voshaar; A Weber
Journal:  Pneumologie       Date:  2011-01-18

8.  [German guideline for diagnosis and management of idiopathic pulmonary fibrosis].

Authors:  J Behr; A Günther; W Ammenwerth; I Bittmann; R Bonnet; R Buhl; O Eickelberg; R Ewert; S Gläser; J Gottlieb; C Grohé; M Kreuter; C Kroegel; P Markart; C Neurohr; M Pfeifer; A Prasse; N Schönfeld; J Schreiber; H Sitter; D Theegarten; A Theile; A Wilke; H Wirtz; C Witt; H Worth; P Zabel; J Müller-Quernheim; U Costabel
Journal:  Pneumologie       Date:  2013-01-16

9.  A new high resolution computed tomography scoring system for pulmonary fibrosis, pleural disease, and emphysema in patients with asbestos related disease.

Authors:  N A Jarad; P Wilkinson; M C Pearson; R M Rudd
Journal:  Br J Ind Med       Date:  1992-02

10.  High-resolution CT of asbestosis and idiopathic pulmonary fibrosis.

Authors:  Masanori Akira; Satoru Yamamoto; Yoshikazu Inoue; Mitsunori Sakatani
Journal:  AJR Am J Roentgenol       Date:  2003-07       Impact factor: 3.959

View more
  5 in total

1.  [Recognize and classify pneumoconiosis].

Authors:  K G Hering; K Hofmann-Preiß
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

Review 2.  [Early recognition of lung cancer in workers occupationally exposed to asbestos].

Authors:  K Hofmann-Preiß; B Rehbock
Journal:  Radiologe       Date:  2016-09       Impact factor: 0.635

3.  Relations between vital capacity, CO diffusion capacity and computed tomographic findings of former asbestos-exposed patients: a cross-sectional study.

Authors:  Alexandra Marita Preisser; Katja Schlemmer; Robert Herold; Azien Laqmani; Claudia Terschüren; Volker Harth
Journal:  J Occup Med Toxicol       Date:  2020-07-01       Impact factor: 2.646

4.  Restrictions of VC and DLCO in relation to asbestos-related computed tomographic findings quantified by ICOERD-based parameters.

Authors:  Lennart Ströker; Kersten Peldschus; Robert Herold; Volker Harth; Alexandra Marita Preisser
Journal:  BMC Pulm Med       Date:  2022-06-20       Impact factor: 3.320

Review 5.  [Occupational diseases of the airways and the lungs].

Authors:  Dennis Nowak; Uta Ochmann; Ullrich G Mueller-Lisse
Journal:  Internist (Berl)       Date:  2021-08-13       Impact factor: 0.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.